BioInformant

Your Global Leader in Stem Cell Market Research

Home » Archives for BioInformant Team

Stem Cell Stocks: A Complete List from “A” to “Z”

By 3 Comments

Biotech investing has become an increasingly popular in recent years. Whether you’re new to stem cell stocks or you’ve been around the block, now could be a good time to place your bets.

The stock market had its largest point drop in recent history on March 9, 2020. On March 12 and March 16, there were two more record-setting point drops. Even though the market has recovered since then, market prices remain attractive across many sectors.

Furthermore, stem cell companies have received substantial support for their use as living therapeutics against COVID-19 induced respiratory complications, such as ARDS. Given these conditions, an intriguing niche within biotech investing is stem cell stocks. [Read more…]

How Long Does It Take for Stem Cell Therapy to Work?

By Leave a Comment

Are you considering having stem cell therapy? If so, you’re probably wondering how long does it takes for stem cell therapy to work.

In this article, we will go over what stem cell therapy is, how the various procedures work, and what to expect post stem cell treatment. It’s important to know that extremely few stem cell procedures are FDA approved, so you will need to do your due diligence.

Keep reading to get informed on this topic. [Read more…]

Development of iPSC-derived Disease Models

By Leave a Comment

Author: ReproCELL

Human induced pluripotent stem cell (iPSC)-based models are a valuable resource for studying disease mechanisms in vitro at the cellular level[1], screening potential new therapeutics[2], and investigating the propensity and mechanism for the development of toxic side effects caused by a drug treatment[3]. Such iPSC-based models enable research to be performed under defined experimental conditions and in a reproducible manner. [Read more…]

7 Tactical Ways to Tell Which Stem Cell Procedures Will Work

By Leave a Comment

Stem cell research used to be controversial specifically because of the attention given to embryonic stem cells, which are derived from human embryos. Thankfully, very little research is done on embryonic stem cells anymore, because there are now better, non-controversial alternatives available for research and clinical use. These alternatives include induced pluripotent stem cells (derived from mature human cells) and adult stem cells, which can be sourced from the blood, bone marrow, and fat tissue, for example. [Read more…]

Stem Cells for ALS: Everything You Need to Know

By Leave a Comment

Although records of ALS aren’t kept everywhere in the country, doctors estimate that between 12,000 and 15,000 people in the United States have it. Though this nerve disease is relatively rare, the illness has a devastating, paralyzing effect on the people who have it.

As of now, ALS isn’t curable. However, many clinical trials show promising results in treating it in the future. Among these trials, the use of stem cells for ALS stands out as an innovative solution.

In this article, we’ll cover everything you need to know about where stem cell therapy stands as a possible solution to Lou Gehrig’s disease. Let’s get started! [Read more…]

BioInformant's World-Class Clients